PUMA BIOTECHNOLOGY, INC. Quarterly Share-based Payment Arrangement, Expense in USD from Q1 2012 to Q2 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Puma Biotechnology, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and growth rate from Q1 2012 to Q2 2024.
  • Puma Biotechnology, Inc. Share-based Payment Arrangement, Expense for the quarter ending June 30, 2024 was $2.06M, a 15.2% decline year-over-year.
  • Puma Biotechnology, Inc. Share-based Payment Arrangement, Expense for the twelve months ending June 30, 2024 was $9.42M, a 12.2% decline year-over-year.
  • Puma Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $10.2M, a 13.4% decline from 2022.
  • Puma Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $11.8M, a 63.8% decline from 2021.
  • Puma Biotechnology, Inc. annual Share-based Payment Arrangement, Expense for 2021 was $32.6M, a 10.8% decline from 2020.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2024 $9.42M $2.06M -$370K -15.2% Apr 1, 2024 Jun 30, 2024 10-Q 2024-08-01
Q1 2024 $9.79M $2.38M -$461K -16.2% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-02
Q4 2023 $10.2M $2.43M -$196K -7.46% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-29
Q3 2023 $10.4M $2.55M -$285K -10.1% Jul 1, 2023 Sep 30, 2023 10-Q 2023-11-02
Q2 2023 $10.7M $2.43M -$788K -24.5% Apr 1, 2023 Jun 30, 2023 10-Q 2024-08-01
Q1 2023 $11.5M $2.84M -$310K -9.85% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-02
Q4 2022 $11.8M $2.63M -$1.62M -38.2% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-29
Q3 2022 $13.5M $2.83M -$1.45M -33.9% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-02
Q2 2022 $14.9M $3.22M -$15M -82.3% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-03
Q1 2022 $29.9M $3.15M -$2.71M -46.3% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-04
Q4 2021 $32.6M $4.25M Oct 1, 2021 Dec 31, 2021 10-K 2024-02-29
Q3 2021 $4.28M -$3.28M -43.4% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-03
Q2 2021 $18.2M Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-04
Q1 2021 $5.86M Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-05
Q3 2020 $7.57M Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-04
Q3 2016 $110M $29.8M +$4.8M +19.2% Jul 1, 2016 Sep 30, 2016 10-Q 2016-11-09
Q2 2016 $105M $28.7M +$535K +1.9% Apr 1, 2016 Jun 30, 2016 10-Q 2016-08-09
Q1 2016 $104M $29.5M +$9.41M +46.8% Jan 1, 2016 Mar 31, 2016 10-Q 2016-05-10
Q4 2015 $94.9M $21.7M Oct 1, 2015 Dec 31, 2015 10-K 2016-02-29
Q3 2015 $25M +$14.5M +139% Jul 1, 2015 Sep 30, 2015 10-Q 2016-11-09
Q2 2015 $28.2M +$21M +293% Apr 1, 2015 Jun 30, 2015 10-Q 2016-08-09
Q1 2015 $20.1M Jan 1, 2015 Mar 31, 2015 10-Q 2016-05-10
Q3 2014 $10.4M +$8.64M +479% Jul 1, 2014 Sep 30, 2014 10-Q 2015-11-09
Q2 2014 $7.17M +$5.72M +396% Apr 1, 2014 Jun 30, 2014 10-Q 2015-08-10
Q4 2013 $7.52M $3.09M -$22.5M -87.9% Oct 1, 2013 Dec 31, 2013 10-K 2016-02-29
Q3 2013 $30M $1.81M +$8.03M Jul 1, 2013 Sep 30, 2013 10-Q 2013-11-12
Q2 2013 $22M $1.45M +$1.25M +630% Apr 1, 2013 Jun 30, 2013 10-Q 2013-08-06
Q1 2013 $20.8M $1.18M +$1.13M +2298% Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09
Q4 2012 $19.6M $25.6M Oct 1, 2012 Dec 31, 2012 10-K 2014-03-03
Q3 2012 -$6.23M Jul 1, 2012 Sep 30, 2012 10-Q 2013-11-12
Q2 2012 $198K Apr 1, 2012 Jun 30, 2012 10-Q 2013-08-06
Q1 2012 $49K Jan 1, 2012 Mar 31, 2012 10-Q 2013-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.